AngioDynamics (ANGO) Reports 2.5M Share Secondary Offering of Common Stock by Holders

November 14, 2016 4:10 PM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

AngioDynamics, Inc. (NASDAQ: ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the “Selling Stockholders”) intend to offer for sale in an underwritten secondary offering 2,500,000 shares of common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), of which the Company intends to repurchase from the underwriter 500,000 shares of common stock. The Selling Stockholders will receive all of the net proceeds from this offering. No shares are being sold by the Company. Barclays Capital Inc. will act as underwriter for the offering.

A shelf registration statement (including a prospectus) relating to the offering of common stock was filed with the SEC on October 3, 2013 and became effective on October 11, 2013.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Equity Offerings

Related Entities

Barclays

Add Your Comment